πŸ‡ΊπŸ‡Έ FDA
Patent

US 6469166

Thiophenopyrimidines

expired A61PA61P25/18A61P25/22

Quick answer

US patent 6469166 (Thiophenopyrimidines) held by Neurocrine Biosciences, Inc. expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P25/18, A61P25/22, A61P25/24, A61P5/04